Neuropsychiatric Symptoms are Related to Blood-biomarkers in Major
Neurocognitive Disorders

Inês      Marques-Aleixo; Arnaldina      Sampaio; Lucimére      Bohn; Flavia      Machado; Duarte      Barros; Oscár      Ribeiro; Joana      Carvalho; José      Magalhães

doi:10.2174/1874609816666230816090934

Abstract

Background: Neuropsychiatric symptoms (NPS) are highly prevalent among individuals with major neurocognitive disorders (MNCD). Objective: Here, we characterized blood biomarkers (metabolic, inflammatory, neurotrophic profiles and total antioxidant), body composition, physical fitness and quality of life (QoL) in individuals with MNCD according to NPS.

Methods: The sample comprised 34 older adults (71.4% women; 74.06±6.03 yrs, with MNCD diagnosis) categorized according to 50th percentile [Low (≤12) or High (≥13)] for NPS (Neuropsychiatric Inventory Questionnaire). Sociodemographic, clinical data, body composition, anthropometric, cognitive assessment (ADAS-Cog), physical fitness (Senior Fitness Test), QoL (QoL-Alzheimer’s Disease scale) were evaluated, and blood samples were collected for biochemical analysis.

Results: Low compared to high NPS group showed higher levels of IL-6, IGF-1and neurotrophic zscore (composite of IGF-1, VEGF-1, BDNF). Additionally, low compared to high NPS group have higher QoL, aerobic fitness and upper body and lower body strength.

Conclusion: The severity of NPS seems to be related to modified neurotrophic and inflammatory outcomes, lower physical fitness, and poor QoL. Strategies to counteract NPS development may preserve the physical and mental health of individuals with MNCD.

Keywords: Blood biomarkers, alzheimer disease, dementia, neuropsychiatric inventory questionnaire, seniors, neuropsychiatric symptoms (NPS), MNCD.

« Previous Next »

Graphical Abstract

[1]
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet  2020; 396(10248): 413-46.
 [http://dx.doi.org/10.1016/S0140-6736(20)30367-6] [PMID: 32738937]

[2]
Gerlach LB, Kales HC. Pharmacological management of neuropsychiatric symptoms of dementia. Curr Treat Options Psychiatry  2020; 7(4): 489-507.
 [http://dx.doi.org/10.1007/s40501-020-00233-9] [PMID: 33344107]

[3]
Chapman KR, Tremont G, Malloy P, Spitznagel MB. The role of sexual disinhibition to predict caregiver burden and desire to institutionalize among family dementia caregivers. J Geriatr Psychiatry Neurol  2020; 33(1): 42-51.
 [http://dx.doi.org/10.1177/0891988719856688] [PMID: 31203702]

[4]
Sampaio A, Marques-Aleixo I, Seabra A, Mota J, Carvalho J. Physical exercise for individuals with dementia: Potential benefits perceived by formal caregivers. BMC Geriatr  2021; 21(1): 6.
 [http://dx.doi.org/10.1186/s12877-020-01938-5] [PMID: 33407194]

[5]
Ng KP, Pascoal TA, Mathotaarachchi S, et al. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease. Transl Neurodegener  2021; 10(1): 1.
 [http://dx.doi.org/10.1186/s40035-020-00225-y] [PMID: 33390174]

[6]
Okabe K, Nagata T, Shinagawa S, et al. Effects of neuropsychiatric symptoms of dementia on reductions in activities of daily living in patients with Alzheimer’s disease. Geriatr Gerontol Int  2020; 20(6): 584-8.
 [http://dx.doi.org/10.1111/ggi.13918] [PMID: 32232948]

[7]
Saari T, Hallikainen I, Hintsa T, Koivisto AM. Neuropsychiatric symptoms and activities of daily living in Alzheimer’s disease: ALSOVA 5-year follow-up study. Int Psychogeriatr  2020; 32(6): 741-51.
 [http://dx.doi.org/10.1017/S1041610219001571] [PMID: 31656211]

[8]
Camina Martín MA, de Mateo Silleras B, Redondo del Río MP. Body composition analysis in older adults with dementia. Anthropometry and bioelectrical impedance analysis: A critical review. Eur J Clin Nutr  2014; 68(11): 1228-33.
 [http://dx.doi.org/10.1038/ejcn.2014.168] [PMID: 25117995]

[9]
Sampaio A, Marques-Aleixo I, Seabra A, Mota J, Marques E, Carvalho J. Physical fitness in institutionalized older adults with dementia: Association with cognition, functional capacity and quality of life. Aging Clin Exp Res  2020; 32(11): 2329-38.
 [http://dx.doi.org/10.1007/s40520-019-01445-7] [PMID: 31927709]

[10]
Hall JR, Wiechmann AR, Johnson LA, et al. Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer’s disease. J Alzheimers Dis  2013; 35(2): 363-71.
 [http://dx.doi.org/10.3233/JAD-122359] [PMID: 23403534]

[11]
Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH. Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology  2011; 77(3): 212-8.
 [http://dx.doi.org/10.1212/WNL.0b013e318225ae07] [PMID: 21753171]

[12]
Nagata T, Kobayashi N, Shinagawa S, Yamada H, Kondo K, Nakayama K. Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. J Neural Transm (Vienna)  2014; 121(4): 433-41.
 [http://dx.doi.org/10.1007/s00702-013-1121-y] [PMID: 24253237]

[13]
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology  1994; 44(12): 2308-14.
 [http://dx.doi.org/10.1212/WNL.44.12.2308] [PMID: 7991117]

[14]
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA  2002; 288(12): 1475-83.
 [http://dx.doi.org/10.1001/jama.288.12.1475] [PMID: 12243634]

[15]
Peters ME, Rosenberg PB, Steinberg M, et al. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: The Cache County Study. Am J Geriatr Psychiatry  2013; 21(11): 1116-24.
 [http://dx.doi.org/10.1016/j.jagp.2013.01.049] [PMID: 23567370]

[16]
Nogueira J, Freitas S, Duro D, Almeida J, Santana I. Validation study of the Alzheimer’s disease assessment scale–cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer’s disease. Clin Neuropsychol  2018; 32 (Suppl. 1): 46-59.
 [http://dx.doi.org/10.1080/13854046.2018.1454511] [PMID: 29566598]

[17]
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry  1984; 141(11): 1356-64.
 [http://dx.doi.org/10.1176/ajp.141.11.1356] [PMID: 6496779]

[18]
Rikli RE, Jones CJ. Development and validation of a functional fitness test for community-residing older adults. J Aging Phys Act  1999; 7(2): 129-61.
 [http://dx.doi.org/10.1123/japa.7.2.129]

[19]
Rikli RE, Jones CJ. Senior fitness test manual. Champaign: Human Kinetics 2001.

[20]
Hesseberg K, Bentzen H, Ranhoff AH, Engedal K, Bergland A. Physical fitness in older people with mild cognitive impairment and dementia. J Aging Phys Act  2016; 24(1): 92-100.
 [http://dx.doi.org/10.1123/japa.2014-0202] [PMID: 26098078]

[21]
Pavasini R, Guralnik J, Brown JC, et al. Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis. BMC Med  2016; 14(1): 215.
 [http://dx.doi.org/10.1186/s12916-016-0763-7] [PMID: 28003033]

[22]
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol  1994; 49(2): M85-94.
 [http://dx.doi.org/10.1093/geronj/49.2.M85] [PMID: 8126356]

[23]
Kwon S, Perera S, Pahor M, et al. What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study). J Nutr Health Aging  2009; 13(6): 538-44.
 [http://dx.doi.org/10.1007/s12603-009-0104-z] [PMID: 19536422]

[24]
Mendes J, Amaral TF, Borges N, et al. Handgrip strength values of Portuguese older adults: A population based study. BMC Geriatr  2017; 17(1): 191-1.
 [http://dx.doi.org/10.1186/s12877-017-0590-5] [PMID: 28835211]

[25]
Sousa-Santos AR, Amaral TF. Differences in handgrip strength protocols to identify sarcopenia and frailty - a systematic review. BMC Geriatr  2017; 17(1): 238.
 [http://dx.doi.org/10.1186/s12877-017-0625-y] [PMID: 29037155]

[26]
Bárrios HSG. Adaptação cultural e linguística e validação do instrumento
QOL-AD para Portugal. 2013. Available from: https://repositorio.ul.pt/handle/10451/8409

[27]
Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation  2011; 123(20): 2292-333.
 [http://dx.doi.org/10.1161/CIR.0b013e3182160726] [PMID: 21502576]

[28]
Patterson MB, Whitehouse PJ, Edland SD, et al. ADCS Prevention Instrument Project: Quality of life assessment (QOL). Alzheimer Dis Assoc Disord  2006; 20(4) (Suppl. 3): S179-90.
 [http://dx.doi.org/10.1097/01.wad.0000213874.25053.e5] [PMID: 17135811]

[29]
Nepal B, Brown LJ, Anstey KJ. Rising midlife obesity will worsen future prevalence of dementia. PLoS One  2014; 9(9): e99305.
 [http://dx.doi.org/10.1371/journal.pone.0099305] [PMID: 25184830]

[30]
Liberman K, Forti LN, Beyer I, Bautmans I. The effects of exercise on muscle strength, body composition, physical functioning and the inflammatory profile of older adults. Curr Opin Clin Nutr Metab Care  2017; 20(1): 30-53.
 [http://dx.doi.org/10.1097/MCO.0000000000000335] [PMID: 27755209]

[31]
Venkatraman VK, Sanderson A, Cox KL, et al. Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer’s disease: The AIBL active trial. Neurobiol Aging  2020; 89: 132-41.
 [http://dx.doi.org/10.1016/j.neurobiolaging.2019.02.030] [PMID: 31324405]

[32]
Westerterp KR. Exercise, energy balance and body composition. Eur J Clin Nutr  2018; 72(9): 1246-50.
 [http://dx.doi.org/10.1038/s41430-018-0180-4] [PMID: 30185845]

[33]
Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: A consensus report. J Am Geriatr Soc  2004; 52(4): 625-34.
 [http://dx.doi.org/10.1111/j.1532-5415.2004.52174.x] [PMID: 15066083]

[34]
Conde-Sala JL, Reñé-Ramírez R, Turró-Garriga O, et al. Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: Discrepancies between patients and caregivers. Am J Geriatr Psychiatry  2014; 22(2): 138-47.
 [http://dx.doi.org/10.1016/j.jagp.2012.07.001] [PMID: 23567444]

[35]
Sampaio A, Marques EA, Mota J, Carvalho J. Effects of a multicomponent exercise program in institutionalized elders with Alzheimer’s disease. Dementia  2019; 18(2): 417-31.
 [http://dx.doi.org/10.1177/1471301216674558] [PMID: 27756836]

[36]
Mendonça DCB, Fernandes DR, Hernandez SS, Soares FDG, Figueiredo K, Coelho FGM. Physical exercise is effective for neuropsychiatric symptoms in Alzheimer’s disease: A systematic review. Arq Neuropsiquiatr  2021; 79(5): 447-56.
 [http://dx.doi.org/10.1590/0004-282x-anp-2020-0284] [PMID: 34161531]

[37]
Kouloutbani K, Venetsanou F, Markati A, Karteroliotis KE, Politis A. The effectiveness of physical exercise interventions in the management of neuropsychiatric symptoms in dementia patients: A systematic review. Int Psychogeriatr  2021; 34(2): 177-90.
 [PMID: 33818342]

[38]
Vreugdenhil A, Cannell J, Davies A, Razay G. A community-based exercise programme to improve functional ability in people with Alzheimer’s disease: A randomized controlled trial. Scand J Caring Sci  2012; 26(1): 12-9.
 [http://dx.doi.org/10.1111/j.1471-6712.2011.00895.x] [PMID: 21564154]

[39]
Lam FMH, Huang MZ, Liao LR, Chung RCK, Kwok TCY, Pang MYC. Physical exercise improves strength, balance, mobility, and endurance in people with cognitive impairment and dementia: A systematic review. J Physiother  2018; 64(1): 4-15.
 [http://dx.doi.org/10.1016/j.jphys.2017.12.001] [PMID: 29289581]

[40]
Sobol NA, Dall CH, Høgh P, et al. Change in fitness and the relation to change in cognition and neuropsychiatric symptoms after aerobic exercise in patients with mild Alzheimer’s disease. J Alzheimers Dis  2018; 65(1): 137-45.
 [http://dx.doi.org/10.3233/JAD-180253] [PMID: 30040719]

[41]
Morris JK, Vidoni ED, Johnson DK, et al. Aerobic exercise for Alzheimer’s disease: A randomized controlled pilot trial. PLoS One  2017; 12(2): e0170547.
 [http://dx.doi.org/10.1371/journal.pone.0170547] [PMID: 28187125]

[42]
Qu Y, Ma YH, Huang YY, et al. Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer’s disease: A systematic review and meta-analysis. Neurosci Biobehav Rev  2021; 128: 479-86.
 [http://dx.doi.org/10.1016/j.neubiorev.2021.07.007] [PMID: 34245759]

[43]
Nowrangi MA. Neuropsychiatric aspects of alzheimer dementia. Psychiatr Clin North Am  2020; 43(2): 383-97.
 [http://dx.doi.org/10.1016/j.psc.2020.02.012] [PMID: 32439028]

[44]
Cunningham C, Campion S, Lunnon K, et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry  2009; 65(4): 304-12.
 [http://dx.doi.org/10.1016/j.biopsych.2008.07.024] [PMID: 18801476]

[45]
Takeda S, Sato N, Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: Relevance to pathogenesis and therapy. Front Aging Neurosci  2014; 6: 171.
 [http://dx.doi.org/10.3389/fnagi.2014.00171] [PMID: 25120476]

[46]
Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation  2003; 107(3): 499-511.
 [http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45] [PMID: 12551878]

[47]
James H. Biomarkers and depressive symptoms in a sample of cognitively intact and Alzheimer’s disease elderly males. Neurosci Med  2011; 2(4): 306-12.

[48]
Vorobyov V, Bobkova N. The brain compensatory mechanisms and Alzheimer-s disease progression: A new protective strategy. Neural Regen Res  2015; 10(5): 696-7.
 [http://dx.doi.org/10.4103/1673-5374.156954] [PMID: 26109935]

[49]
Holmgren S, Hjorth E, Schultzberg M, et al. Neuropsychiatric symptoms in dementia—A role for neuroinflammation? Brain Res Bull  2014; 108: 88-93.
 [http://dx.doi.org/10.1016/j.brainresbull.2014.09.003] [PMID: 25224917]

[50]
Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev  2001; 7: 18-31.
 [PMID: 11579746]

[51]
Xu LZ, Li FY, Li BQ, et al. Decreased levels of insulin-like growth factor-1 are associated with alzheimer’s disease: A meta-analysis. J Alzheimers Dis  2021; 82(3): 1357-67.
 [http://dx.doi.org/10.3233/JAD-210516] [PMID: 34151815]

[52]
Swerdlow RH, Burns JM, Khan SM. The Alzheimer’s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim Biophys Acta Mol Basis Dis  2014; 1842(8): 1219-31.
 [http://dx.doi.org/10.1016/j.bbadis.2013.09.010] [PMID: 24071439]

[53]
Loeffler DA. Modifiable, non-modifiable, and clinical factors associated with progression of Alzheimer’s disease. J Alzheimers Dis  2021; 80(1): 1-27.
 [http://dx.doi.org/10.3233/JAD-201182] [PMID: 33459643]

[54]
Büttiker P, Weissenberger S, Esch T, et al. Dysfunctional mitochondrial processes contribute to energy perturbations in the brain and neuropsychiatric symptoms. Front Pharmacol  2023; 13: 1095923.
 [http://dx.doi.org/10.3389/fphar.2022.1095923] [PMID: 36686690]

[55]
Marques-Aleixo I, Beleza J, Sampaio A, et al. Preventive and therapeutic potential of physical exercise in neurodegenerative diseases. Antioxid Redox Signal  2021; 34(8): 674-93.
 [http://dx.doi.org/10.1089/ars.2020.8075] [PMID: 32159378]

Rights & Permissions Print Cite

Article Metrics

18

3

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1874609816666230816090934	Print ISSN 1874-6098
Publisher Name Bentham Science Publisher	Online ISSN 1874-6128

Current Aging Science

Neuropsychiatric Symptoms are Related to Blood-biomarkers in Major Neurocognitive Disorders

Abstract

Graphical Abstract

Related Journals

Related Books

Related Articles